Jennifer Ton is a distinguished leader in the biotechnology sector, currently serving as the Founder and President of BioRox® Inc., a consulting firm that specializes in Chemistry, Manufacturing, and Controls (CMC) strategy and development. With a robust background in gene therapy and biotech process development,...
Jennifer Ton is a distinguished leader in the biotechnology sector, currently serving as the Founder and President of BioRox® Inc., a consulting firm that specializes in Chemistry, Manufacturing, and Controls (CMC) strategy and development. With a robust background in gene therapy and biotech process development, Jennifer has cultivated a wealth of expertise that spans early-stage and late-stage product development, as well as commercial product support. Her leadership at BioRox® Inc. is characterized by a commitment to fostering collaborative projects that drive business success and innovation in the biotech landscape.
At BioRox®, Jennifer oversees a diverse portfolio of clients, including those in gene therapy, biopharmaceuticals, industrial biotech, green technology, and specialty technology sectors. Her strategic approach encompasses comprehensive CMC strategy formulation, meticulous supply chain planning, and quality guidance, ensuring that clients navigate the complexities of regulatory compliance and product development with confidence. Jennifer's hands-on experience in process development and manufacturing support is complemented by her proficiency in facility design, where she leverages her knowledge in equipment design and process engineering to optimize operational efficiency.
Jennifer has authored several critical regulatory documents, including Biologics License Application (BLA) CMC sections and Investigational New Drug (IND) submissions, showcasing her deep understanding of the regulatory landscape. Her expertise extends to risk assessment, operational risk management, and the implementation of Corrective and Preventive Action (CAPA) programs, ensuring that her clients maintain the highest standards of quality and safety throughout the product lifecycle. With a passion for advancing biotechnology, Jennifer Ton continues to be a pivotal figure in shaping the future of the industry through her innovative strategies and unwavering dedication to excellence.
